Although the pathogenesis of CD30+ pseudolymphoma remains unclear, the drug administration is one of the triggers for this cutaneous reaction [120,121,122] and the reactive T cells are overstimulated during the causative agent’s treatment and as a result, the pseudolymphoma might cause after a long duration of the incubation period [120]. The gene discussed is TNFRSF8; the disease is pseudolymphoma.